D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer

Clinical trial NCT03861156 · COMPLETED

Trial details

NCT number: NCT03861156
Sponsor: InventisBio Co., Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor NSCLC EGFR T790M

Start date: 2019-02-28
Primary completion: 2021-08-15
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.